20 LATEST RESOURCES (62 INDEXED)
Pentoxifylline as Adjunctive Therapy in Cognitive Deficits and Symptoms of Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial · July 2023
Abstracts
Journal of Psychopharmacology
Can Brexpiprazole Be Switched Safely in Patients with Schizophrenia and Dopamine Supersensitivity Psychosis? A Retrospective Analysis in a Real-World Clinical Practice · July 2023
Abstracts
Journal of Psychopharmacology
Body Mass Index, Waist Circumference, Insulin, and Leptin Plasma Levels Differentiate between Clozapine-Responsive and Clozapine-Resistant Schizophrenia · June 2023
Abstracts
Journal of Psychopharmacology
The Role of Risperidone in the Treatment of Children and Adolescents with Anorexia Nervosa · June 2023
Abstracts
Journal of Psychopharmacology
Baseline Cognitive Function Predicts Full Remission of Suicidal Symptoms among Patients with Treatment-Resistant Depression and Strong Suicidal Ideation After Low-Dose Ketamine Infusion · June 2023
Abstracts
Journal of Psychopharmacology
Estimating the Per-Protocol Effect of Lithium on Suicidality in a Randomized Trial of Individuals with Depression or Bipolar Disorder · April 2023
Abstracts
Journal of Psychopharmacology
A Transdiagnostic Systematic Review and Meta-Analysis of Ketamine’s Anxiolytic Effects · April 2023
Abstracts
Journal of Psychopharmacology
Psilocybin-Assisted Therapy for Major Depressive Disorder: An Exploratory Placebo-Controlled, Fixed-Order Trial · March 2023
Abstracts
Journal of Psychopharmacology
A Bayesian Meta-Analysis of Topiramate’s Effectiveness for Individuals with Alcohol Use Disorder · January 2023
Abstracts
Journal of Psychopharmacology
Therapeutic Uses of Psychedelics for Eating Disorders and Body Dysmorphic Disorder · December 2022
Abstracts
Journal of Psychopharmacology
Efficacy of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder with Somatic Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial with Clinical and Electroencephalography Evidence · October 2022
Abstracts
Journal of Psychopharmacology
Characteristics of Adverse Reactions among Antipsychotic Drugs Using the Korean Adverse Event Reporting System Database from 2010 to 2019 · June 2022
Abstracts
Journal of Psychopharmacology
Efficacy and Safety of Supraphysiologic Doses of Levothyroxine for Patients with Bipolar Depression in Adults: A Systematic Review · May 2022
Abstracts
Journal of Psychopharmacology
Males and Females Differ in Reported Sexual Functioning with Escitalopram Treatment for Major Depressive Disorder: A CAN-BIND-1 Study Report · May 2022
Abstracts
Journal of Psychopharmacology
Can Pediatric Bipolar Disorder Be Successfully Treated When Comorbid with Conduct Disorder? A Secondary Analysis of Clinical Trials of Risperidone, Olanzapine, Quetiapine, Ziprasidone, and Aripiprazole · May 2022
Abstracts
Journal of Psychopharmacology
Association of Benzodiazepines, Z-Drugs, Pregabalin, and Melatonin with Traffic Accidents: A Nationwide Cohort and Case-Crossover Study in Danish Adults · April 2022
Abstracts
Journal of Psychopharmacology
A Randomized Controlled Trial of 3,4-Methylenedioxymethamphetamine (MDMA) and Fear Extinction Retention in Healthy Adults · February 2022
Abstracts
Journal of Psychopharmacology
Psilocybin Use Is Associated with Lowered Odds of Crime Arrests in US Adults: A Replication and Extension · January 2022
Abstracts
Journal of Psychopharmacology
Incident Infection during the First Year of Treatment – A Comparison of Clozapine and Paliperidone Palmitate Long-Acting Injection · January 2022
Abstracts
Journal of Psychopharmacology
Lifetime Use of MDMA/Ecstasy and Psilocybin Is Associated with Reduced Odds of Major Depressive Episodes · January 2022
Abstracts
Journal of Psychopharmacology